NovaBay Pharmaceuticals Stock (AMEX: NBY) stock price, news, charts, stock research, profile.
You can purchase shares of NovaBay Pharmaceuticals (AMEX:NBY) through any online brokerage.
Other companies in NovaBay Pharmaceuticals’s space includes: 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN), Sonoma Pharmaceuticals (NASDAQ:SNOA) and Hepion Pharmaceuticals (NASDAQ:HEPA).
NovaBay Pharmaceuticals has a consensus price target of $3.90.
The stock price for NovaBay Pharmaceuticals (AMEX: NBY) is $0.69 last updated September 25, 2024 at 12:46 PM EDT.
There are no upcoming dividends for NovaBay Pharmaceuticals.
NovaBay Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for NovaBay Pharmaceuticals.
NovaBay Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.